Clinical Trials Browser

Phase 3 × Carcinoma, Non-Small-Cell Lung × anlotinib × Clear all

NCT03866980 2024-04-03

A Study of Anti-PD-1 AK105 in Patients With Metastatic Nonsquamous Non-small Cell Lung Cancer

Phase 3 Terminated

Carcinoma, Non-Small-Cell Lung

NCT04325763 2022-03-31

A Study of TQB2450 in Subjects With Stage III Non-Small Cell Lung Cancer(NSCLC)

Phase 3 Unknown

Carcinoma, Non-Small-Cell Lung

NCT04797806 2021-03-15

SAINT

Phase 3 Unknown

Carcinoma, Non-Small-Cell Lung